Evidence map›Paper›PMID 20547752›Full record

ArticleMolecular and cellular biology2010

Zinc finger protein Gfi1 controls the endotoxin-mediated Toll-like receptor inflammatory response by antagonizing NF-kappaB p65.

Ehssan Sharif-Askari, Lothar Vassen, Christian Kosan, Cyrus Khandanpour, Marie-Claude Gaudreau, Florian Heyd, Taro Okayama, Jianmin Jin, Meghan E B Rojas, H Leighton Grimes and 2 more

Open access · greenAbstract read
In one paragraph

Article in Molecular and cellular biology, 2010. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 17 papers.

0numbers the graph read from it
0cells of the map it votes in
17citing papers in PubMed
0.6field-weighted citation impact, top 32% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

17 citing papers in PubMed, 34 citations in OpenAlex.

  1. Trial
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Zinc finger protein ZBTB20 promotes Toll-like receptor-triggered innate immune responses by repressing IκBα gene transcription.Proceedings of the National Academy of Sciences of the United States of America · 2013
    Article
  17. Zinc in innate and adaptive tumor immunity.Journal of translational medicine · 2010
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors at 5 institutions in 4 countries.

Ehssan Sharif-AskariInstitut de Recherches Cliniques de Montreal, 110 Avenue des Pins Ouest, Montréal, Québec H2W 1R7, Canada.
Lothar Vassen
Christian Kosan
Cyrus Khandanpour
Marie-Claude Gaudreau
Florian Heyd
Taro Okayama
Jianmin Jin
Meghan E B Rojas
H Leighton Grimes
Hui Zeng
Tarik Möröy
Montreal Clinical Research Institute · CACincinnati Children's Hospital Medical Center · USBeijing Tongren Hospital · CNCapital Medical University · CNInstitut für Medizinische Informatik, Biometrie und Epidemiologie · DE

Funding

Canadian Institutes of Health Research
6 · The paper itself

Abstract

Endotoxin (bacterial lipopolysaccharide [LPS]) causes fatal septic shock via the Toll-like receptor 4 (TLR-4) protein present on innate immunity effector cells, which activates nuclear factor kappa B (NF-kappaB), inducing proinflammatory cytokines, including tumor necrosis factor alpha (TNF-alpha). An early step in this process involves nuclear sequestration of the p65-RelA NF-kappaB subunit, enabling transcriptional activation of target inflammatory cytokine genes. Here, we analyzed the role of the nuclear zinc finger protein Gfi1 in the TLR response using primary bone marrow-derived macrophages. We show that upon LPS stimulation, expression of Gfi1 is induced with kinetics similar to those of nuclear translocation of p65 and that Gfi1 interacts with p65 and inhibits p65-mediated transcriptional transactivation by interfering with p65 binding to target gene promoter DNA. Gfi1-deficient macrophages show abnormally high mRNA levels of the TNF-alpha gene and many other p65 target genes and a higher rate of TNF promoter occupancy by p65 than wild-type cells after LPS stimulation, suggesting that Gfi1 functions as an antagonist of NF-kappaB activity at the level of promoter binding. Our findings identify a new function of Gfi1 as a general negative regulator of the endotoxin-initiated innate immune responses, including septic shock and possibly other severe inflammatory diseases.

Indexed as

AnimalsBase SequenceCell LineDNADNA-Binding ProteinsDNA PrimersHumansImmunity, InnateInflammationLipopolysaccharidesMacrophagesMiceMice, Inbred C57BLMice, KnockoutPromoter Regions, GeneticRNA, MessengerDNADNA-Binding ProteinsDNA PrimersGFI1 protein, humanGfi1 protein, mouseLipopolysaccharidesRela protein, mouseRNA, MessengerToll-Like ReceptorsTranscription Factor RelATranscription FactorsTumor Necrosis Factor-alpha

Identifiers

PMID20547752
PMCPMC2916436
OpenAlexW2122994961

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.